ALFA Finder| Revenue growth | 26% YoY for FY26; 22% YoY for Q4FY26. |
|---|---|
| Margins | FY26 EBITDA margin at 17.1% (down from 19.7% YoY). |
| Demand visibility | Stable trends; optimistic for gradual improvement. |
| Management confidence | High; targets ₹20k+ topline by 2030. |
Growth
Q4FY26 revenue up 22% YoY (₹3,333 cr). FY26 revenue reached ₹13,611 cr with EBITDA growth at 9%.
Outlook
Aiming for ₹15,000 cr revenue in FY27 with double-digit growth and mid-teen EBITDA CAGR by FY30.
Risks
Geopolitical risks in the Middle East impacting costs/supply chains and monsoon trajectory affecting rural sentiment.
Earnings Call filed with NSE, NSE: MARICO. Summary written with AI assistance from the document.
Marico Ltd: key numbers
- Share price
- ₹907.45
- Market cap
- ₹1,17,987 Cr
- Revenue (annual)
- ₹13,611 Cr
- Net profit (annual)
- ₹1,762 Cr
- P/E (TTM)
- 58.5×Sector 41.3×
- Promoter holding
- 58.83%-0.08% QoQ
- FII holding
- 22.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marico Ltd
All →Marico Acquisition Worth ₹35 Cr
Marico will acquire 51% of Bonorizon Consumer Ventures via primary subscription for up to Rs 35 crore in cash. Completion is expected within 90 days of signing definitive agreements.
- Value
- ₹35.00 Cr
- Execution
- Within 90 days from signing of definitive agreements
Marico Acquisition Worth ₹113.7 Cr
Marico bought a further 20% stake in Cosmix Wellness for Rs. 113.65 Crore cash. Its holding rises from 60% to 80%.
- Value
- ₹113.7 Cr
Marico Annual General Meeting
Marico seeks postal ballot approval to appoint Rohit Jawa as Independent Director from 1 January 2027 for five years. Remote e-voting ends 7 December 2026.
Marico Earnings Call Transcript: Key Takeaways
Strong Q2: revenue +13%, EBITA +27%, PAT +31%, EBITA margin 18.2%, helped by softer copra and mix. FY27 EBITDA guidance raised to mid-20s growth, while A&P spend rose 44%.
- Call
- Guides 13% growth
Marico Management Change
Marico's board appointed Mr. Rohit Jawa as Additional Independent Director for a five-year term. Shareholder approval will be sought via postal ballot.
Marico Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹3,897 Cr (+13%), EBITDA ₹709 Cr (+27%), PAT ₹550 Cr (+31%); volume-led growth with Foods and Premium Personal Care scaling.